Wasatch Advisors’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-32,163
| Closed | -$96K | – | 322 |
|
|
2017
Q4 | $96K | Sell |
32,163
-1,129
| -3% | -$3.37K | ﹤0.01% | 293 |
|
|
2017
Q3 | $120K | Buy |
+33,292
| New | +$120K | ﹤0.01% | 324 |
|
|
2017
Q2 | – | Sell |
-9,345
| Closed | -$85K | – | 365 |
|
|
2017
Q1 | $85K | Sell |
9,345
-153,366
| -94% | -$1.39M | ﹤0.01% | 344 |
|
|
2016
Q4 | $15.9M | Buy |
162,711
+1,274
| +0.8% | +$125K | 0.24% | 85 |
|
|
2016
Q3 | $16M | Buy |
161,437
+42,013
| +35% | +$4.18M | 0.24% | 97 |
|
|
2016
Q2 | $14.6M | Sell |
119,424
-943
| -0.8% | -$115K | 0.22% | 106 |
|
|
2016
Q1 | $18.9M | Buy |
120,367
+6,557
| +6% | +$1.03M | 0.29% | 92 |
|
|
2015
Q4 | $5.26M | Sell |
113,810
-1,126
| -1% | -$52K | 0.07% | 211 |
|
|
2015
Q3 | $11.1M | Buy |
114,936
+7,784
| +7% | +$755K | 0.15% | 152 |
|
|
2015
Q2 | $14.7M | Sell |
107,152
-1,430
| -1% | -$196K | 0.16% | 155 |
|
|
2015
Q1 | $19.3M | Buy |
108,582
+35,796
| +49% | +$6.38M | 0.2% | 130 |
|
|
2014
Q4 | $14.6M | Buy |
72,786
+14,869
| +26% | +$2.97M | 0.15% | 146 |
|
|
2014
Q3 | $11.7M | Sell |
57,917
-4,193
| -7% | -$844K | 0.12% | 169 |
|
|
2014
Q2 | $9.98M | Buy |
62,110
+239
| +0.4% | +$38.4K | 0.1% | 203 |
|
|
2014
Q1 | $12.4M | Buy |
+61,871
| New | +$12.4M | 0.12% | 186 |
|